PSQGX
Price
$18.68
Change
+$0.01 (+0.05%)
Updated
Oct 17 closing price
Net Assets
190.14M
RLBCX
Price
$38.75
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

PSQGX vs RLBCX

Header iconPSQGX vs RLBCX Comparison
Open Charts PSQGX vs RLBCXBanner chart's image
Port Street Quality Growth Institutional
Price$18.68
Change+$0.01 (+0.05%)
VolumeN/A
Net Assets190.14M
American Funds American Balanced R3
Price$38.75
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
PSQGX vs RLBCX Comparison Chart in %
View a ticker or compare two or three
VS
PSQGX vs. RLBCX commentary
Oct 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSQGX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBCX has more cash in the bank: 266B vs. PSQGX (190M). PSQGX pays higher dividends than RLBCX: PSQGX (1.63) vs RLBCX (1.49). PSQGX was incepted earlier than RLBCX: PSQGX (12 years) vs RLBCX (23 years). PSQGX (1.10) is less costly to investors than RLBCX (0.89). RLBCX is a more actively managed with annual turnover of: 44.00 vs. PSQGX (7.00). RLBCX has a lower initial minimum investment than PSQGX: RLBCX (250) vs PSQGX (2000). RLBCX annual gain was more profitable for investors over the last year : 8.34 vs. PSQGX (3.84). RLBCX return over 5 years is better than : 40.24 vs. PSQGX (28.70).
PSQGXRLBCXPSQGX / RLBCX
Total Expense Ratio0.970.89109%
Annual Report Gross Expense Ratio1.100.89124%
Fund Existence12 years23 years-
Gain YTD8.10214.36456%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets190M266B0%
Annual Yield % from dividends1.631.49110%
Returns for 1 year3.848.3446%
Returns for 3 years29.8749.2661%
Returns for 5 years28.7040.2471%
Returns for 10 years86.3872.18120%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VRDN24.211.20
+5.22%
Viridian Therapeutics
ACI19.740.51
+2.65%
Albertsons Companies
PRFX1.24N/A
-0.40%
PainReform Ltd
BOC13.76-0.10
-0.72%
Boston Omaha Corp
ASRT0.80-0.02
-2.90%
Assertio Holdings